BIOPORTO DIAGNOSTICS A/S: Financial statements 2020
CVR: 18645882
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 23,203,609 and a net result of DKK -42,627,971 compared with DKK -67,290,651 the year before. That is a decrease of 12.8% compared with the year before. The profit margin was -183.7%. Equity in the 2020 report amounted to DKK -404,626,128. The company had 16 employees in the financial year.
- Revenue
- DKK 23,203,609
- Gross Profit
- DKK -10,556,384
- Profit/Loss
- DKK -42,627,971
- Equity
- DKK -404,626,128
- Total Assets
- DKK 22,018,519
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 23.2 mio. | -10.6 mio. | -42.6 mio. | -404.6 mio. | 16 |
| 2019 | 26.6 mio. | -6.9 mio. | -67.3 mio. | -362 mio. | 17 |
| 2018 | 25.9 mio. | -417 t. | -43.7 mio. | -294.7 mio. | 17 |
| 2017 | 26 mio. | -2.9 mio. | -35.3 mio. | -251 mio. | 16 |
| 2016 | 20.7 mio. | 6 mio. | -28.9 mio. | -216.1 mio. | 19 |
Official annual report
How creditworthy is BIOPORTO DIAGNOSTICS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2019. Revenue came to DKK 26,621,259, and the net result was DKK -67,290,651.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.